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We	 investigated	 the	 neuropsychological	 characteristics,	 cranial	 MRI,	 and	 P300	 ERPs	 in	
patients	suffering	from	vascular	cognitive	 impairment	with	no	dementia	(VCIND).	A	study	
was	performed	on	68	cases	of	VCIND	after	stroke.	The	cranial	MRI	patterns	and	P300	waves	
of	the	patients	were	compared	with	those	of	56	stroke	patients	without	cognitive	impairment	
and	52	healthy	subjects.	The	MoCA	(Montreal	Cognitive	Assessment)	was	also	used	to	assess	
their	mental	status.	The	proportion	of	patients	with	frontotemporal	lesions,	multiple	lesions,	
and	 leukoaraiosis	 (LA)	 in	 the	VCIND	group	was	greater	 than	 that	 in	 the	stroke	group.	The	
cognitive	impairment	in	patients	with	the	former	deficiencies	was	more	significant.	The	MoCA	
scores	in	the	VCIND	group	were	significantly	lower,	and	the	P300	latency	was	significantly	
longer,	as	compared	with	other	 two	groups.	The	P300	latency	inversely	correlated	with	the	
MoCA	score.	Patients	with	frontotemporal	lesions,	multiple	lesions,	and	LA	are	susceptible	to	
cognitive	impairment.	The	MoCA	score	and	the	P300	test	are	helpful	for	the	early	diagnosis	
of	VCIND.
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INTRODUCTION
Vascular	 cognitive	 impairment	 (VCI)	 describes	
a	 broad	 class	 of	 syndromes,	 from	 mild	 cognitive	
disorders	 to	dementia	caused	by	cerebrovascular	 risk	
factors	 and	 obvious	 or	 not	 obvious	 cerebrovascular	
diseases.	The	 latter	 cover	 the	whole	 process	 of	VCI,	
from	a	mild	 to	 a	 severe	degree,	 and	 include	vascular	
cognitive	 impairment	 with	 no	 dementia	 (VCIND),	
vascular	 dementia,	 mixed	 dementia,	 and	 other	 types	
[1].	 VCIND	 refers	 to	 the	 early	 or	 mild	 cognitive	
impairment	 caused	 by	 cerebrovascular	 damage	 [2].	
VCIND	is	a	hidden	disease,	and	the	degree	of	cognitive	
impairment	 usually	 does	 not	 reach	 the	 diagnostic	
criteria	 for	 clear	 dementia	 [1].	The	 incidence	 rate	 of	
VCIND	is	reportedly	about	26.9%	at	3	months	after	a	
stroke	 [3].	Early	diagnosis	and	adequate	 intervention	
for	 VCIND	 patients	 can	 improve	 the	 prognosis;	
otherwise,	 VCIND	 will	 progress	 into	 dementia	 [4].	
Studies	on	VCI	have	mainly	been	focused	on	vascular	
dementia;	 thus,	 research	 on	 VCIND,	 which	 has	 the	
best	 clinical	 intervention	 result,	 remains	 relatively	
limited.	 The	 pathogenic	 factors	 of	 VCIND	 have	
not	 been	 fully	 determined,	 and	 methods	 for	 early	
diagnosis	are	lacking.	Our	study	aimed	to	observe	the	
neuropsychological,	imaging,	and	P300	characteristics	
of	 VCIND	 patients	 to	 improve	 the	 early	 diagnostic	
rate	and	provide	a	basis	for	early	intervention.
METHODS
Subjects. A	 total	 of	 68	 VCIND	 cases	 (42	 men	 and	
26	 women,	 inpatients	 and	 outpatients)	 who	 had	 a	
stroke	 were	 included	 in	 the	 study.	 The	 patients,	 
44-	to	78-year-old,	with	a	mean	age	of	64	±	2.4	years,	
were	recruited	between	2006	and	2011.	The	diagnostic	
criteria	for	VCIND	(based	on	the	criteria	by	Rockwood	
et	al.	[2])	are	as	follows:	presence	of	a	cerebrovascular	
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disease,	 neuropsychological	 evaluation	 (including	
evidence	 of	 cognitive	 impairment),	 cognitive	
impairment	occurring	within	3	months	after	stroke,	a	
causal	 relationship	 between	 cerebrovascular	 disease	
and	 cognitive	 impairment,	 excluding	 other	 diseases,	
and	 Hanchinski	 ischemic	 score	 ≥7	 not	 meeting	 the	
dementia	 diagnosis	 criteria.	 The	 exclusion	 criteria	
included	Alzheimer’s	disease	and	the	presence	of	other	
conditions,	 such	 as	 mental	 retardation,	 depression,	
mental	disease,	and	aphasia	 that	affects	 the	Montreal	
Cognitive	Assessment	(MoCA)	score.
Fifty-six	 (30	 men	 and	 26	 women)	 patients	 with	
stroke	(outpatients	and	inpatients)	were	also	included	
as	 subjects.	These	 subjects	were	38-	 to	 76-year-old,	
with	 an	 average	 age	 of	 63	 ±	 2.5	 years.	 Stroke	 was	
diagnosed	 in	accordance	with	 the	diagnostic	 criteria	
[5] amended	 by	 the	 European	 Stroke	 Initiative	 and	
confirmed	by	cranial	MRI,	with	the	scale	assessment.	
A	clinical	and	cognitive	 function	 test	was	performed	
for	patients	without	cognitive	impairment.
Fifty-two	 control	 cases	 (32	men	 and	 20	women),	
healthy	 individuals	 that	 checked	 into	 the	 hospital	
at	 the	 same	 time,	were	 also	 included.	The	members	
of	 this	 group	were	 from	 35	 to	 72	 year	 old,	with	 an	
average	age	of	63	±	3.57	years.	They	had	no	obvious	
lesions	and	no	cognitive	impairment	under	the	clinical	
and	cognitive	function	test.
Cranial MRI. The MRI	 imaging	 studies	 were	
carried	 out	 on	 a	Novus	 1.5	T	 superconducting	MRI	
(Siemens,	Germany).	The	patients	were	subjected	to	an	
axial	T1WI,	T2WI,	FLAIR,	and	DWI,	and	the	location	
of	 the	stroke	 lesions,	 their	number,	and	 the	presence	
of	leukoaraiosis	(LA)	were	observed.	Leukoaraiosis	is	
defined	as	sites	of	periventricular	or	deep	white	matter	
with	a	high	signal	 intensity	and	no	clear	edges	under	
T2WI	 and	 FLAIR;	 DWI	 does	 not	 show	 obviously	
high	 signals,	 and	 TIWI	 shows	 equal	 or	 slightly	
lower	 signals.	Leukoaraiosis	 excludes	 the	decreased	
white	 matter	 density	 caused	 by	 multiple	 sclerosis,	
intracranial	 infection,	 radiation	 encephalopathy,	
anthracemia,	 hypotension,	 anemia,	 demyelinating	
disease,	adrenoleukodystrophy,	and	other	diseases.
Cognitive Function Check. The	MoCA	assessment	
scale	 was	 used	 to	 evaluate	 the	 cognitive	 function	
of	 the	 patients.	 The	 MoCA	 has	 11	 items	 assessing	
eight	 cognitive	 domains.	 These	 domains	 include	
visuospatial/executive	 abilities,	 naming,	 memory,	
attention,	 language,	 abstraction,	 delayed	 recall,	 and	
calculation	ability,	with	a	 total	possible	 score	of	30.	
One	more	 score	 is	 added	 for	 subjects	with	 less	 than	
12	years	of	education.	The	higher	the	score,	the	better	
is	the	cognitive	function	of	the	subject;	MoCA	scores	
below	26	indicate	cognitive	impairment.
P300 Wave. Recording	of	this	ERP	was	performed	
in	 all	 patients	 within	 48	 h	 after	 they	were	 enrolled	
in	 the	 study.	 A	 Britain	 Oxford’s	 multimedia	 
EMG/EP	 system	 was	 adopted.	 In	 a	 quiet	 shielded	
room,	 the	 subjects	were	 asked	 to	 lie	 supine,	 remain	
calm,	and	concentrate.	According	to	 the	 international	
10/20	EEG	system,	a	 recording	electrode	was	placed	
along	 the	 central	 line,	 a	 reference	 electrode	 was	
placed	 on	 the	 right	 earlobe,	 and	 a	 ground	 electrode	
was	 on	 the	 forehead.	 The	 electrode	 impedance	 was	
maintained	 below	 5	 kW,	 and	 the	 analysis	 time	 was	
600	msec.	 Short	 sound	 stimulation	was	 used	 in	 the	
experiment.	The	probability	for	nontarget	stimulation	
(frequency	 1,000	Hz)	 showed	 regularly	was	 80%	 at	
a	signal	strength	of	80	dB.	The	probability	 for	 target	
stimulation	 (frequency	 4,000	Hz)	 showed	 randomly	
and	alternated	with	nontarget	stimulation	was	20%	at	a	
signal	strength	of	90	dB.	The	subjects	were	instructed	
to	press	a	key	for	target	stimulation,	and	the	instrument	
automatically	recorded	the	response	time.	The	test	was	
repeated	twice,	and	the	means	were	calculated.
Statistical Analysis. SPSS	16.0	statistical	software	
was	used	to	analyze	the	data.	The	measured	data	were	
expressed	 as	means	 ±	 s.e.m.	The	ANOVA	and	 t-test	
were	performed.	The	counting	data	were	indicated	by	
percentage,	and	 the	c2	 test	was	performed.	Pearson’s	
correlation	analysis	was	also	used	to	analyze	the	data.	
Differences	with	P	<	0.05	were	considered	statistically	
significant.
RESULTS
Comparison of General Characteristics. The	 three	
examined	 groups	 did	 not	 differ	 from	 each	 other	 in	
terms	 of	 gender	 composition	 and	 cultural	 degree.	
The	proportion	of	patients	with	diabetes mellitus	and	
smoking	history	in	the	VCIND	group	was	higher	than	
those	 in	other	 two	groups.	The	proportion	of	patients	
with	 hypertension	 and	 hyperlipidemia	 in	 the	VCIND	
group	 was	 higher	 than	 that	 in	 the	 control	 group	 
(Table	1).
Cognitive Function. The	total	MoCA	scores	of	the	
VCIND	patients	were	significantly	lower	than	those	of	
other	 two	groups	 (P	<	0.01).	The	 total	MoCA	scores	
of	 the	 stroke	group	did	not	 significantly	differ	 from	
those	 of	 the	 control	 group.	 The	MoCA	 subitems	 in	
the	VCIND	group	were	lower	than	those	in	the	stroke	
group,	whereas	the	MoCA	scores	of	the	control	group	
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TABLE 1. Comparison of Basic Clinical Data among Three Groups 
Т а б л и ц я 1. Порівняння основних клінічних даних у пацієнтів трьох груп
Group
Number	
of	cases
Gender Educational	level Focal	areas Lesion	number
Hyper-
tension
Diabe-
tes 
Hyper-
lipid-
emia 
Smok-
ing	
history men women
uni-
versity 
senior
high	
school 
junior	
high	
school
fronto-
temporal	
lobar
other multiple single 
VCIND 68 42(61.76) 26(38.24) 9(13.24) 51(75.00) 8(11.76) 30(44.12) 38(55.88) 43(63.24) 25(36.76) 33(48.53) 38(55.88) 30(44.12) 37(54.41)
Stroke 56 30(53.57) 26(46.43) 6(10.71) 45(80.36) 5(8.93) 11(19.64) 45(80.36) 22(39.29) 34(60.71) 24(42.86) 16(28.57) 22(39.29) 13(23.21)
Control 52 32(61.54) 20(38.46) 7(13.46) 40(76.92) 5(9.62) 13(25.00) 12(23.08) 9(17.31) 12(23.08)
Comparison	
among	groups
(χ2) 1.76 0.96 8.31** 7.06** 10.56** 15.84** 8.80* 19.36**
Footnotes.	Case	and	percentage	(in	brackets)	are	shown.	**P	<	0.01	and	*P	<	0.05.
differed	significantly	 (P	<	0.05,	Table	2)	 in	 terms	of	
memory,	 visuospatial/executive	 abilities,	 attention,	
and	 abstract	 ability.	 However,	 the	 MoCA	 subitem	
scores	 in	 the	stroke	group	did	not	differ	significantly	
from	those	in	the	control	group.
Number of Lesions, Lesion Position, LA, and 
Cognitive Function of VCIND Patients. The	
proportion	of	patients	with	 frontotemporal	 lesions	 in	
the	VCIND	group	was	55.9%,	 i.e.,	much	higher	 than	
that	in	the	stroke	group	(19.6%,	c2	=	8.31,	P	<	0.01).	
The	 proportion	 of	 the	 patients	 with	 frequently	
occurring	 lesions	 was	 63.2%,	 also	 higher	 than	 that	
in	 the	 stroke	 group	 (39.3%,	 c2	 =	 7.06,	 P	 <	 0.01).	
The	 proportion	 of	 patients	 with	 LA	 in	 the	 VCIND	
group	was	58.8%,	also	significantly	higher	 than	 that	
in	 the	 stroke	 group	 (30.4%,	 c2	 =	 10.02,	P	 <	 0.01).	
The	 proportion	 of	 the	 lesions	 in	 the	 left	 cerebral	
hemisphere	 in	 the	VCIND	 group	was	 67.6%,	which	
did	 not	 significantly	 differ	 from	 that	 in	 the	 stroke	
group	 (57.1%,	c2	=	1.45,	P	>	0.05).	The	position	of	
lesions,	the	number	of	lesions,	and	the	presence	of	LA	
in	 the	VCIND	group	 directly	 affected	 the	 degree	 of	
impairment	 of	 the	 cognitive	 function.	More	 lesions	
corresponded	 to	 lower	 MoCA	 scores	 and	 greater	
degrees	 of	 impairment	 of	 the	 cognitive	 function	 for	
patients	 with	 frontotemporal	 lesions	 and	 patients	 
with	LA	(Table	3).
P300 Characteristics. The	 P300	 latencies	 for	
patients	 of	 the	 VCIND	 group	 were	 significantly	
longer	 than	 those	 in	 the	 stroke	 and	 control	 groups	
TABLE 2. Comparison of the MoCA Rating Scale among Three Groups (Score)
Т а б л и ц я 2. Порівняння оцінок за рейтинговою шкалою МоСа у пацієнтів трьох груп
Item
VCIND	 
(68	cases)
Stroke	 
(56	cases)
Control	 
(52	cases)		
Memory	ability 3.71	±	0.77** 4.67	±	0.68 4.70	±	0.47
Language	fluency 2.71	±	0.47 2.71	±	0.46 2.75	±	0.44
Vision	space/executive	ability 2.59	±	0.87** 4.67	±	0.48 4.70	±	0.46
Naming	ability 2.71	±	0.47 2.95	±	0.22 2.75	±	0.44
Attention	and	computing	ability 4.06	±	0.90** 5.48	±	0.51 5.55	±	0.60
Abstract	epitome	ability 1.40	±	0.51* 1.71	±	0.46 1.80	±	0.41
Orientation	ability 5.24	±	0.56 5.57	±	0.51 5.45	±	0.60
Total 22.18	±	1.62** 27.76	±	1.14 27.70	±	1.08
Footnotes.	Means	±	s.e.m.	are	shown.	One	and	two	asterisks	show	cases	of	significant	difference	vs	two	other	groups	with	P	<	0.05	and	 
P <	0.01,	respectively.
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(P	 <	 0.01).	 No	 significant	 difference	 in	 the	 P300	
latency	was	observed	between	the	stroke	group	and	the	
control	group	(P	>	0.05).	The	P300	amplitude	did	not	
show	significant	differences	among	 the	 three	groups	
(P	>	0.05,	Table	4).
Correlation between the P300 Parameters and 
MoCA. Correlation	 analysis	was	 carried	 out	 among	
the	P300	 latency,	amplitude,	and	MoCA	score	of	 the	
VCIND	group.	The	MoCA	score	 inversely	correlated	
with	the	P300	latency	(r	=	–0.798,	P	=	0.001),	but	did	
not	correlate	significantly	with	 the	amplitude	of	 this	
wave	(r	=	0.057,	P	=	0.846).
DISCUSSION
Searching	 for	 the	 related	 pathogenic	 factors,	 simple	
and	 effective	 test	 methods,	 and	 methods	 for	 early	
detection	 of	 mild	 cognitive	 function	 impairment	 is	
necessary	for	adequate	treating	of	VCIND	patients.
Many	 s tudies 	 demonst ra ted 	 tha t 	 vascular	
cognitive	 impairment	 is	 related	 to	 the	 risk	 factors	of	
cerebrovascular	diseases,	the	characteristics	of	stroke,	
and	 the	 characteristics	 of	 the	 patient.	 At	 present,	
diabetes,	 hypertension,	 heart	 diseases,	 and	 other	
disorders	are	believed	to	be	related	to	the	occurrence	
of	cognitive	impairment.	However,	compared	to	other	
factors,	 diabetes	 is	more	 closely	 related	 to	 vascular	
cognitive	 impairment	 [6]	 because	 it	 causes	 cerebral	
arteriosclerosis,	 microcirculation	 disturbance,	 and	
small-vessel	 disease.	 Finally,	 it	 leads	 to	 neuronal	
degeneration,	 which	 causes	 cognitive	 function	
impairment.	 In	 our	 study,	 the	 incidence	 of	diabetes 
mellitus	 was	 clearly	 higher	 in	 the	 VCIND	 group	
TABLE 3. Numbers of Lesions, Position of Lesions, Leukoaraiosis, and Cognitive Function in VCIND Patients
Т а б л и ц я 3. Кількість уражень мозку, їх локалізація, кількість випадків лейкоарайозу та оцінка когнітивних функцій у 
пацієнтів з VCIND 
Group
Number	of	lesions Position	of	lesions Leukoaraiosis
multiple single frontotemporal	lobar other yes no
Number	of	
cases
43 25 30 38 40 28
MoCA 22.00	± 1.83 23.70	± 1.83 21.90	± 1.37 23.60	± 0.84 21.80	± 1.03 23.30	± 0.67
T	value 2.55 3.34 3.85
P	value 0.02 0.004 0.001
Footnote.	Means	±	s.e.m.	are	shown.
TABLE 4. Comparison of Latency and Amplitude of the Central-Line P300 between the Groups
Т а б л и ц я 4. Міжгрупове порівняння латентних періодів та амплітуд потенціалу Р300 (відведення по центральній лінії) у 
пацієнтів і контрольних суб’єктів
Group
Number	of	
cases
P300	latency,	msec P300	amplitude,	μV
VCIND 68 379.12±25.68** 4.04±0.75
Stroke 56 325.10±13.52 4.25±0.74
Control 52 324.27±11.74 3.96±0.49
F	value 144.66 2.02
P value 0.000 0.136
Footnotes.	Means	±s.e.m.	are	shown.	Two	asterisks	show	significant	difference	in	comparison	of	the	VCIND	group	vs	the	other	two	groups	
with	P	<	0.01.
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than	 in	 other	 groups,	 which	 indicates	 that	 diabetes	
may	 be	 more	 closely	 related	 to	 cognitive	 function	
impairment.	Smoking	is	an	independent	risk	factor	for	
cerebrovascular	 diseases.	The	proportion	of	patients	
who	smoke	in	the	VCIND	group	was	evidently	higher	
than	 that	 in	 the	stroke	group,	which	 is	 in	accordance	
with	 the	 related	 reports	 that	 smoking	 increases	 the	
risk	of	stroke.	Smoking	also	positively	correlated	with	
cognitive	function	impairment	[7].
A	few	studies	reported	that	the	number	and	position	
of	 cerebral	 infarcts	 correlate	 with	 the	 degree	 of	
cognitive	 impairment.	 Straaten	 et	 al.	 [8]	 found	 that	
a	 history	 of	 stroke	 recurrence	 and	 multiple	 strokes	
are	 important	 causes	 for	 sharp	 declines	 in	 cognitive	
function.	Our	findings	indicate	that	the	VCIND	group	
had	 more	 lesions	 compared	 with	 the	 stroke	 group.	
Within	 the	VCIND	group,	 the	patients	with	multiple	
lesions	 had	 lower	 MoCA	 scores	 than	 patients	 with	
single	lesions.	Considering	that	the	number	of	lesions	
is	 related	 to	 the	 level	of	cognitive	 function,	 it	might	
also	be	related	to	the	cumulative	brain	damage	caused	
by	multiple	 lesions	and	 the	 influence	of	disorders	 in	
the	frontal	subcortical	loop.	Some	researchers	reported	
that	lesions	in	the	left	cerebral	hemisphere,	forebrain,	
and	 frontal	 lobe	 might	 play	 more	 important	 roles	
in	 the	 occurrence	 of	 cognitive	 impairment	 [9].	We	
found	that	the	proportion	of	frontotemporal	lesions	in	
the	VCIND	group	was	higher	 than	 that	 in	 the	 stroke	
group.	Meanwhile,	 the	patients	 in	 the	VCIND	group	
with	 frontotemporal	 lesions	had	 lower	MoCA	scores	
than	 patients	 with	 lesions	 at	 other	 locations.	 This	
agrees	 with	 the	 statement	 that	 the	 frontotemporal	
lobe	 is	more	 closely	 related	 to	 cognitive	 functions.	
The	proportion	of	left	cerebral	hemisphere	lesions	did	
not	differ	significantly	between	 the	 two	groups.	This	
observation	contrasts	with	the	results	of	the	mentioned	
report;	however,	the	discrepancy	may	be	related	to	the	
fewer	number	of	cases.	
Leukoaraiosis	 is	a	 term	used	 in	 imaging	diagnosis	
coined	by	Hachinski	in	1987	[10]	to	describe	a	group	
of	 diseases	 caused	 by	 multiple	 pathogenic	 factors	
that	 lead	 to	 nonspecific	 changes	 in	 the	 cerebral	
white	matter.	At	 present,	LA	 is	 considered	 a	 part	 of	
the	 human	 aging	 process	 that	 can	 lead	 to	 cognitive	
impairment	 [11].	 The	 specific	 mechanism	 and	 the	
pathogenic	 changes	 in	 the	 periventricular	 white	
matter	affect	three	limbic	loops,	the	Papez	circuit,	the	
Livingston	 circuit,	 and	 the	 defensive	 circuit,	 which	
are	 related	 to	memory,	 emotion,	behavior,	 and	other	
intellectual	abilities	[12].	The	 incidence	of	LA	in	 the	
VCIND	group	was	obviously	higher	 than	 that	 in	 the	
stroke	group.	In	addition,	 the	patients	with	LA	in	 the	
VCIND	group	clearly	showed	signs	of	decline	 in	 the	
cognitive	 function,	which	 indicates	 that	LA	patients	
are	susceptible	to	impaired	cognitive	function.
Cognitive	 function	 tests	play	an	 important	 role	 in	
diagnosing	VCI	at	an	early	stage.	Nasreddine	et	al.	[13]	
formulated	 the	MoCA	 scale	 basing	 on	 their	 clinical	
experience,	 with	 reference	 to	 the	 cognitive	 project	
settings	and	scoring	criteria	of	 the	mini-mental	 state	
examination.	Lee	et	al.	 [14]	 indicated	that	 the	MoCA	
scale	 provides	 comparatively	 high	 sensitivity	 and	
specificity	for	mild	cognitive	function	impairment.	We	
found	 that,	compared	with	 the	stroke	control	groups,	
the	 VCIND	 patients	 clearly	 had	 greater	 cognitive	
function	impairment,	and	their	total	MoCA	score	was	
lower	 than	 that	 in	 other	 two	 groups.	 The	 subitems	
mainly	 show	 impairment	 in	 memory,	 visuospatial/
executive	 functions,	 attention,	 calculation,	 and	
abstract	ability.	The	above-mentioned	study	indicated	
that	 MoCA	 is	 applicable	 for	 VCI	 screening,	 which	
coincides	with	our	current	results.
The	 P300	 ERP	 is	 a	 forward	 electrotropic	 change	
developing	 within	 about	 300	 msec	 after	 target	
stimulation.	All	 kinds	 of	 sensory	modes	 can	 induce	
the	 endogenous	 P300	 component.	 The	 effects	 of	
physical	 stimulation	 parameters	 on	 this	 wave	 are	
minimal,	 but	 the	 P300	 characteristics	 are	 closely	
related	 to	 advanced	 psychological	 activities	 and	
cognitive	 processing	 in	 the	 human	 brain.	 The	 P300	
reflects	multilevel	 psychological	 activities,	 such	 as	
memory,	 perception,	 understanding,	 judgment,	 and	
emotions;	recording	of	this	potential	is	widely	applied	
in	cognitive	function	research	[15].	The	P300	latency	
reveals	 the	 evaluation	 of	 the	 stimulation	 during	
cognitive	 activities,	 and	 it	 indicates	 the	 information	
processing	 rate.	 Its	 amplitude	 indicates	 the	 degree	
of	 mobilization	 of	 effective	 resources	 when	 the	
brain	 processes	 information,	 and	 it	 also	 indicates	
the	 excitability	 of	 the	 brain	 [16].	 Our	 results	 and	
findings	of	other	authors	indicate	that	the	P300	latency	
reflects,	to	some	extent,	other	aspects	of	the	functional	
status	of	 the	brain,	 including	 such	characteristics	 as	
sensation,	 attention,	 memory,	 information	 coding,	
cognitive	 integration	 rate,	 and	 other	 activities [17]. 
The	amplitudes	of	 the	 two	P300	components	did	not	
differ	significantly	from	each	other	in	our	study,	which	
was	probably	related	to	the	mildness	of	the	cognitive	
function	 impairment	 in	 the	VCIND	patients	and	also	
to	 large	 individual	differences.	Meanwhile,	 the	P300	
latency	 in	 the	VCIND	group	was	significantly	 longer	
compared	with	 that	 in	 the	control	group,	which	may	
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be	indicative	of	the	rather	high	sensitivity	of	the	P300	
latency.	The	 latter	parameter	of	P300	 in	 the	VCIND	
group	showed	abnormalities	when	cognitive	 function	
was	mildly	impaired.	Braverman	et	al.	[18]	found	that	
a	 longer	P300	 latency	could	be	used	 to	predict	early	
cognitive	 decline,	which	 coincides	with	 our	 current	
results.	 Bennys	 et	 al.  [19]	 reported	 that	 the	 P300	
latency	 is	 longer	among	patients	with	mild	cognitive	
impairment,	and	it	inversely	correlates	with	the	MMSE	
score.	Correlation	analysis	 in	our	 study	 showed	 that	
the	P300	latency	negatively	correlates	with	the	MoCA	
score.	 This	 result	 confirms	 that	 prolonged	 P300	
latencies	 objectively	 reflect	mild	 cognitive	 function	
impairment,	 and	 this	phenomenon	cannot	be	used	 to	
determine	the	cognitive	function	impairment	related	to	
the	impaired	neurological	function	after	stroke.
In	conclusion,	 stroke	patients	with	 frontotemporal	
lesions	 and	 multiple	 lesions	 and	 also	 patients	 with	
LA	are	 susceptible	 to	cognitive	 impairment.	VCIND	
patients	 have	 obvious	 abnormalities	 in	 neurological	
characteristics	 and	 P300	 latencies.	 The	 cognitive	
function	impairment	in	these	patients	can	be	detected	
earlier	by	combining	neurological	tests	with	the	P300	
test,	 which	 will	 facilitate	 timely	 intervention	 and	
improve	prognosis.
Considering	 that	 the	 studied	 subjects	were	mostly	
elderly	persons,	even	small	numbers	of	cases	qualify	
for	 the	 study.	 The	 results	 of	 the	 study	 are	 also	
dependent	on	the	sensitivity	of	the	cognitive	function	
determination	 scale.	The	 relatively	 small	 number	 of	
subjects	limits	the	applicability	of	the	results	to	VCIND	
patients,	which	should	be	 improved	by	increasing	the	
sampling	size	and	other	methods	in	future	studies.
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Р	е	з	ю	м	е
Ми	досліджували	нейропсихологічні	характеристики,	дані	
магніторезонансного	дослідження	мозку	(MRI)	та	пов’язані	
з	подією	ЕЕГ-потенціали	P300	у	пацієнтів	зі	зумовленим	су-
динними	захворюваннями	ураженням	когнітивних	функцій	
при	відсутності	деменції	(VCIND).	Дослідження	було	прове-
дено	у	68	випадках	VCIND,	котре	розвивалося	після	інсуль-
ту.	Дані	MRI	та	характеристики	P300	у	групі	VCIND	порів-
нювали	з	такими	у	двох	інших	групах	(у	56	пацієнтів	після	
інсульту	без	розладів	когнітивних	функцій	та	у	52	здорових	
суб’єктів).	Шкалу	MoCA	(Монреальська	когнітивна	оцінка)	
використовували	для	оцінки	 інтелектуального	статусу	об-
стежених.	Відносна	кількість	випадків	фронтотемпоральних	
уражень,	множинних	уражень	та	лейкоарайозу	(ЛА)	у	групі	
VCIND	була	більшою,	ніж	у	групі	пацієнтів	з	неускладне-
ним	інсультом.	Розлади	когнітивних	функцій	у	пацієнтів	із	
зазначеними	вище	ураженнями	були	більш	істотними.	Оцін-
ки	згідно	з	MoCA	в	групі	VCIND	були	достовірно	нижчи-
ми,	а	латентний	період	P300	був	 істотно	тривалішим,	ніж	
у	двох	 інших	групах.	Пацієнти	з	фронтотемпоральними	та	
множинними	ураженнями	й	ЛА	особливо	схильні	до	когні-
тивних	розладів.	Використання	оцінок	за	MoCA	та	відведен-
ня	потенціалу	Р300	є	вельми	доцільними	в	аспекті	ранньої	
діагностики	VCIND.	
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